Aim | Outcome/RE-AIM element | Indicator | Definition |
---|---|---|---|
Specific Aim 1: efficacy | Primary outcome: control of NCD conditions | Condition-specific “at-goal” metrics | % of enrolled NCD patients achieving “at-goal” status (Table 2), at completion of the study period |
Secondary outcome 1: tobacco use | Tobacco use status | % of enrolled NCD patients who were using tobacco at enrollment who are nonusers or who have reduced by > 50% their tobacco intake, at completion of the study period | |
Secondary outcome 2: alcohol use | Alcohol use status | % of enrolled NCD patients who were alcohol drinkers at enrollment who are nondrinkers or who have reduced by > 50% alcohol intake, at completion of the study period | |
Specific Aim 2: implementation | Reach | Home visit coverage | % of enrolled NCD patients having a CHW home visit, measured monthly |
Clinic visit coverage | % of enrolled NCD patients having an MLP visit at the clinic, measured monthly according to the patients indicated to be seen that month based on protocol-based guidelines | ||
Demographic, geographic barriers and facilitators | % of enrolled NCD patients whose CHW has GPS-mapped their households, describing barriers/facilitators to individuals’ access, and identifying contributors to variation/inequities | ||
Loss to follow-up | % of patients, stratified by demographic data and NCD conditions, who are lost to follow-up after enrollment | ||
Monthly patient touch-points | Number of monthly per-patient touch-points, including interactions by both MLPs and CHWs | ||
Efficacy | Evidence-based hypertension management | % of enrolled hypertension patients in accordance with evidence-based recommendations, as prescribed by clinical algorithms, assessed quarterly by EHR audits | |
Evidence-based diabetes management | % of enrolled diabetes patients in accordance with evidence-based recommendations, as prescribed by clinical algorithms, assessed quarterly by EHR audits | ||
Evidence-based COPD management | % of enrolled COPD patients in accordance with evidence-based recommendations, as prescribed by clinical algorithms, assessed quarterly by EHR audits | ||
Adoption | Village-cluster adoption | % of intended village clusters receiving intervention | |
Timely adoption | % of intended village clusters rolling-out intervention within 3 months of schedule, according to local governance decisions to roll-out the intervention | ||
CHW adoption | % of CHWs trained in intervention implementation within the first 6 months % of trained CHWs retained in their positions at completion of the study period | ||
MLP adoption | % of MLPs trained in intervention implementation % of trained MLPs retained in their positions at completion of the study period | ||
Implementation | Care integration | % of all NCD patients enrolled at the facilities seen by CHWs at home within the first month | |
CHW supervision model | % of scheduled CHW supervision field visits completed, stratified by CHN and district, measured quarterly % of scheduled quarterly data review meetings held with CHWs and CHNs, measured quarterly | ||
CHW home visit fidelity | % of enrolled NCD patients with 100% of algorithm-indicated home visits received % of topics included at each session as dictated by the condition-specific algorithms, assessed during the CHW supervision field visits by CHNs, measured quarterly | ||
Referrals | % of patients appropriately referred to MLP care as indicated by the clinical algorithms, assessed during the CHW supervision field visits by CHNs, measured quarterly % of patients referred by CHWs seen by MLPs within the prescribed time window according to the clinical algorithms (e.g., 24 h, 72 h, 1 week), measured quarterly | ||
MLP supervision model | % of enrolled NCD patients appropriately referred to see a physician by MLPs as indicated by the clinical algorithms, assessed during monthly physician supervision sessions, measured quarterly | ||
MLP visit fidelity | % of enrolled NCD patients with 100% of algorithm-indicated facility visits received, assessed during monthly physician supervision sessions, measured quarterly % of diagnostic, treatment, and counseling topics included at each session as dictated by the condition-specific algorithms, assessed during monthly physician supervision sessions, measured quarterly | ||
Implementation challenges | Exploratory and hypothesis-generating as revealed through FGDs and KIIs with CHWs, CHNs, MLPs, physicians, patients, and other relevant community stakeholders | ||
Maintenance | Total intervention cost | Cost of each intervention component and total costs using the Joint Learning Network costing methodology | |
Intervention initiation costs | % breakdown of initial (one-time) costs for intervention (training, equipment, etc.) | ||
Intervention maintenance costs | % breakdown of maintenance (recurring) costs (ongoing training, personnel, materials, and other) | ||
Facility vs. community costs | % of costs of healthcare divided between facility level and community level | ||
Geographic cost variation | Characterization of variance in costs between village clusters and districts within the intervention catchment area | ||
Out-of-pocket patient costs | % costs of healthcare divided between facility level and community level | ||
Integrated intervention cost-effectiveness analysis | Pre/post-intervention marginal effectiveness for primary outcomes | ||
Cost per unit | Intervention cost per enrolled patient Intervention cost per capita Projected cost to scale intervention nationally, based on known incidence and prevalence of each condition |